相关实验视频

Updated: Jun 24, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

化学结构和生物试验描述的协同作用,用于在药物发现中增强分子性质预测

Maximilian G Schuh¹, Davide Boldini¹, Stephan A Sieber¹

¹TUM School of Natural Sciences, Department of Bioscience, Center for Functional Protein Assemblies (CPA), Technical University of Munich, 85748 Garching bei München, Germany.

Journal of chemical information and modeling

|June 5, 2024

概括

这项研究引入了一种新的计算方法,用于使用测试描述和化学结构来预测分子性质. 它使得即使数据有限,也能准确地预测,加速药物发现.

科学领域:

计算化学和化学信息学.
药物的发现和开发.
机器学习在药理学中的应用.

背景情况:

准确预测分子性质对于加速药物开发至关重要.
目前的in silico方法数据有限,限制了它们的应用到具有良好的特征的测试.
存在对预测模型的需求,这些模型可以概括为具有有限或没有实验数据的新型试验.

研究的目的:

通过整合测试描述和化学结构来开发一种新的计算方法来预测分子性质.
为了能够准确地预测具有有限或没有可用的实验数据的测试 (零射击预测).
展示开发的工具在为高通量选活动量身定制选库时的实用性.

主要方法:

使用自主监督学习框架,将文字测试描述与化学结构信息结合起来.
该方法在FS-Mol对零射击预测任务的基准数据集上进行了评估.
该方法的性能在一项高通量选活动的回顾性案例研究中进行了评估.

主要成果:

开发的计算方法在FS-Mol基准上实现了最先进的性能,用于零射击分子性质预测.
与各种深度学习方法相比,该工具在没有可用数据的测试中预测特性的准确度更高.
追溯案例研究显示,针对选图书馆的定制有希望的结果,有助于识别活性分子.

结论:

这种新的计算方法通过克服数据限制,在分子性质预测方面取得了重大进展.
该方法加速了活性分子的早期识别,简化了药物发现和开发管道.
该工具具有很大的潜力,可以更有效地识别新疗法.

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Drug-Receptor Bonds

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

Agonism and Antagonism: Quantification

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...